Publications & Reports

Delivery of a heterologous antigen by a registered Salmonella vaccine (STM1).

Bachtiar EW, Sheng KC, Fifis T, Gamvrellis A, Plebanski M, Coloe PJ, Smooker PM
Department of Biotechnology and Environmental Biology, RMIT University, P.O. Box 71, 3083, Bundoora, Vic., Australia.


STM1 is an aro A(-) attenuated mutant of Salmonella enterica serovar Typhimurium, and is a well-characterised vaccine strain available to the livestock industry for the prevention of salmonellosis in chickens. This strain has potential for heterologous antigen delivery, and here we show that the strain can be used to deliver a model antigen, ovalbumin, to immune cells in vitro and in vivo. Two plasmid constructs expressing the ovalbumin gene were utilised, one of which uses a prokaryotic promoter and the other the CMV promoter (DNA vaccine). In vitro, STM1 carrying ovalbumin-encoding plasmids was able to invade dendritic cells and stimulate a CD8(+) cell line specific for the dominant ovalbumin epitope, SIINFEKL. In vivo, spleen cells were responsive to SIINFEKL after vaccination of mice with ovalbumin-encoding plasmids in STM1, and finally, humoral responses, including IgA, were induced after vaccination.


  • Journal: FEMS Microbiology Letters
  • Published: 24/10/2003
  • Volume: 227
  • Issue: 2
  • Pagination: 211-217